Sheldon L. Koenig - Mar 7, 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Sheldon L. Koenig
Stock symbol
ESPR
Transactions as of
Mar 7, 2023
Transactions value $
-$27,510
Form type
4
Date filed
3/8/2023, 03:21 PM
Previous filing
Sep 20, 2022
Next filing
Mar 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$27.5K -5.44K -2.72% $5.06 195K Mar 7, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of performance-based restricted stock units.
F2 Consists of 194,815 shares of common stock held, including 1,999 shares recently acquired in Esperion's Employee Stock Purchase Plan.